Yobe State Project
Total Page:16
File Type:pdf, Size:1020Kb
'-" -1 I YOBE STATE PROJECT ORIGINAL : English COT,NTRYAIOTF: NIGERIA Proiect Name: YOBE STATE Approval year: 1999 Launching year: 1999 Reportins Period (JANUARY- DECEMBER :2006) Proiectvearofthibreport: (circleone) I 2 3 4 5 6 7 (8) 9 10 Date submitted: JAI\IUARY 2007 NGDO partner: CBM JOS 8,h YEAR ANNUAL PROJECT TECHNICAL RBPORT SUBMITTED TO TECHNICAL CONSULTATIVE COMMITTEE (TCC) Hz TccJ4 eEt DEADLINE FOR SUBMISSION: Btn C^$ To Co? APOC Management by 31 January for March TCC meeting fiE AB To APOC Management by 31 Julv for September TCC F, ,!i \,qI Aoi 0 8 FFV ?I}fl? P"[u6I tl- i i ! AFRICANPROGRAMME FOR ! ONCHOCERCTASTS CONTROL (APOC) ANN[]At, I',RU.tl',( 't' I u(lllNl(lAL l{[]l'oR'l' 'l'o 'l'lr('l tNl('u\l ('( )NSt ll I A I lVl', ( ( )MN'll'l'l'llli ('l'(.(') IiNDORSIiMIINT' Please confirlll You ltave reatl this report by signing in the a lt[)t'ol)l'ia tc sltacc. OIrFI(ll,lRS to sig n the re;lttrt: Country: N ieeria ) .*Llt,lca N ational Cloord intttttr Niunc: l.*.t Aq c. .i. 6.. .[.G ri. !- Sigrralure .p*^rg(- [)atc: . ].c.1 ql lza;:v.n. Zonal Onclro C'oordiluttttr Narn.,f,t-, e-1t-( t\\ . C G*'=Uot*trc' -@^,n Signature: c{- -4, I)atc: .).V. '2,<:.P.r. -l lris re;rort hus bcelt prel)al'e(l by Nlarne. [.] .Sara (tvlrs) I )csigrrirl itttr : C't,ttt'tlittlttot Signatul'e' ffil+-s-.-, l)ate ,)'r' .lAN i(x)7 ii Table of contents ACROITYMS .............v DEFINITIONS YI FOLLOW UP ON TCC RECOMMENDATIONS..... 1 EXECUTTVE SI]MMARY 3 SECTION l: BACKGROUND INFORIVIATION....... ......................4 1.1 . GeNeRar- INFoRMATToN ............. 4 1.1 I Description of the project (briefly). 4 1.1 2. Partnership 5 t.2. PopularroN ............... 7 SECTION 2: IMPLEMENTATION OF CDTI ..............9 2.t. TtunlrNe oF ACTrvrrrES............. .........9 2.2. Aovocncv ...................... l0 2.3. MostI,tzetloN, SENSITIzATIoN AND HEALTH EDUCATIoN oF AT RISK coMMuNnIes 10 2.4. CouvcrNrry rNVoLVEMENT............ t2 2.5. CnpncnvBUrLDrNG.. ......14 2.6. TReanrrnNTS.............. .....16 2.6.1. Treatmentfigures............. Enor! Bookmark not deJined 2.6.2 What are the causes of absenteeism? .......... .................19 2.6.3 What are the reasons for refusals? ................ ............... 19 2.6.4 BrieJly describe all lmown and verified serious adverse events (SAEs) thot Enor! Bookmark not defined 2.6.5. Trend of treatment achievementfrom CDTI project inception to the current year20 2.7. ORoenrNc, sroRAcE AND DELIVERy oF IVERMECTTN 2t 2.8. CoupruNrry sELF-MoNrroRrNG eNp SrnreHoLDERs MeerrNc ............22 2.9. SuppRvrsroN ...................23 2.9.1. Provide aflow chart of supervision hierarchly............. ..................24 2.9.2. Wat were the main issues identiJied during supervision? ..............................24 2.9.3. Was a supervision checHist used?......... Error! Booknark not deJlned 2.9.4. What were the outcomes at esch level of CDTI implementation supervision? Enor! Boohmarh not delined 2.9.5. Was feedback given to the person or groups supervised? Enor! Boohmarh not deJined 2.9.6. How was thefeedbackused to improve the overall performance of the project? Error! Bookmark not deJined SECTION 3: SUPPORT TO CDTI 3.1. EqunvreNr ,................,....25 3.2. FrNnNcrnl coNTRrBUTloNs oF THE pARTNERS AND coMMUNrrrES............. ..............26 3.3. OrHsn FoRMs oF coMMUNrry suppoRT ............. Ennon! Booxuanx Nor DEFTNED. 3.4. ExpENottuREpERAcTrvrry......... .....Ennon!Booxlr,LRr(NorDEFrNED. SECTION 4: SUSTAINABILITY OF CDTI .................28 4.1. INrnnNel; INDEnENDENT pARTrcrpAToRy MoNrroRrNc; EveluerroN ......... ...........29 4.1.I Was Monitoring/evaluation carried out during the reporting pertod? (tick any of thefollowingwhich are applicable)........... ............29 4.1.2. What were the recommendations? ..............29 ttl 4.1.3. How have they been implemented? .................... Enor! Bookmark not defined 4.2. SusrerxngrLrry oF eRoJECTS: ILAN AND sET TARGETS (MANDAToRY AT..... ...........29 Yn 3) 29 4.2.1. Planning at all relevant levels.... ................... 29 4.2.2. Funds ................... 29 4.2.3 Transport (replacement and maintenance) ................... 30 4.2.4. Other resources ................... 30 4.2.5. To what extent has the plan been implemented............... ...............30 4.3. INrecRenoN............. ......30 4.3.1. Ivermectin delivery mechsnisms................ ...................30 4.3.2. Training... ...............30 4.3.3. Joint supervision and monitoring with other progroms .... ............. 30 4.i.4. Release offundsfor project activities... ......31 4.3.5. Is CDTI included in the PHC budget?............... ...........31 4.3.6. Describe other health programmes that are using the CDTI structure and how this was achieved. What hove been the achievements?............. ....................31 4.3.7. Describe others issues considered in the integration of CDTL.........................31 4.4. OpenerroNAl RESEARCH .....31 4.4.1. Summarize in not more than one half of a page the operationsl research undertaken in the project area within the reporting period. ........ 31 4.4.2. How were the results applied in the project? ........ 3 I SECTION 5r StRnncTHS, WEAKNESSES, CHALLENGES, AhtD OPPORTI]NITIES .....31 SECTION 6: UMQUE FEATURES OF THE PROJECT/OTHER MATTERS. ERROR! BOOKMARK NOT DEFINED. IV Acronyms APOC African Programme for Onchocerciasis Control ATO Annual Treatrnent Objec tive ATrO Annual Training Obj ective CBO Community-Based Organization CBM Christoffel Blinden Mission CDD Community-Directed Distributor CDTI Community-Directed Treatnent with Ivermectin CSM Community Self-Monitoring FLHF First line Health Facility LGA Local Govemment Area LOCT Local Govemment Oncho. Control Team MOH Ministry of Health NGDO Non-Governmental Development Organization NGO Non-Governmental Organization NOCP National Onchocerciasis Control Programme NOTF National Onchocerciasis Task Force PEC Primary Eye Care PHC Primary health care REMO Rapid Epidemiological Mapping of Onchocerciasis SAE Severe adverse event SHM Stakeholders meeting SOCT State Onchocerciasis Control Team TCC Technical Consultative Committee (APOC scientific advisory goup) TOT Trainer of trainers UNICEF United Nations Children's Fund UTG Ultimate Treatment Goal wHo World Health Organization v Definitions (i) Total population: the total population living in meso/hyper-endemic communities within the project area (based on REMO and census taking). (ii) Eligible population: calculated as 84o/o of the total population in meso/hyper- endemic communities in the project area. (iii) Annual Treatment Objective: (ATO): the estimated number of persons living in meso/hyper-endemic areas that a CDTI project intends to treat with ivermectin in a given year. (iv) Ultimate Treatment Goal (UTG): calculated as the maximum number of people to be treated annually in meso/hyper endemic areas within the project area, ultimately to be reached when the project has reached full geographic coverage (normally the project should be expected to reach the UTG at the end of the 3d year ofthe project). (v) Therapeutic coverage: number of people treated in a given year over the total population (this should be expressed as a percentage). (vi) Geographical coverage: number of communities treated in a given year over the total number of meso/hyper-endemic communities as identified by REMO in the project area (this should be expressed as a percentage). (viD Inteeration: delivering additional health interventions (i.e. vitamin A supplements, albendazole for LF, screening for cataract, etc.) through CDTI (using the same systems, training, supervision and personnel) in order to maximise cost- effectiveness and empower communities to solve more of their health problems. This does not include activities or interventions carried out by community distributors outside of CDTI. (viii) Sustainability: CDTI activities in an area are sustainable when they continue to function effectively for the foreseeable future, with high treatment coverage, integrated into the available healthcare service, with strong community ownership, using resources mobilised by the community and the government. (ix) Community self-monitoring (CSM): The process by which the community is empowered to oversee and monitor the performance of CDTI (or any community- based health intervention programme), with a view to ensuring that the progrcmme is being executed in the way intended. It encourages the community to take full responsibility of ivermectin distribution and make appropriate modifications when necessary. 4 FOLLOW UP ON TGG REGOMTIENDATIONS Using the table below, fill in the recommendations of the last TCC on the project and describe how they have been addressed. TCC session 2t Number of TCC ACTIONS TA"KEN BY FOR TCC/APOC Recommeudation RECOMMEIVDATIONS THE PR.OJECT MGT USE ONLY in the Repoil The Therapeutic The involvement of coverage and health staffis gradual involvement of health however, all health staff in CDTI staffwill be involve after their training in CDTI Involvement of women This is still maintained. in advocacy and It is difficult to change mobilization. CDDs ratio because CDD/population ratio community select and is still low with poor support their CDDs supervision however, the project has embark on intensive mobilization of community on this. Train all staffon CDTI The project has not achieved this. There is a plan for training all health staff by next year. Integrate drug delivery Drugs delivery will be into PHC to reduce cost fully integrated by and ensure 2007. sustainability. Continue sensitization,